Poly Medicure Ltd Stock Analysis

BSE: 531768 | NSE: POLYMED | Medical Equipment/Supplies/Accessories | Mid Cap

BSE Share Price 29-Nov-2022 18:01
974.90 -2.15 (-0.22%)

DeciZen - Make an Informed Decision on Poly Medicure

Overall Rating

1. Quality

2. Valuation


3. Price Trend

Poly Medicure Price Chart

P/E Ratio (SA) :
Market Cap :
9,371.7 Cr.
52-wk low :
52-wk high :
Bole Toh?

1. Is Poly Medicure Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Poly Medicure Ltd is a good quality company.

2. Is Poly Medicure Ltd undervalued or overvalued?

The key valuation ratios of Poly Medicure Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Poly Medicure Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Poly Medicure Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

10 Year X-Ray of Poly Medicure:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Poly Medicure Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

ROCE % 26.8%25.1%21.2%17.8%16.5%17.1%14.1%17.2%15.4%12.4%-
Value Creation Index

Growth Parameters

Growth Parameters Colour Code Guide

Sales 252312374394440508587646747879967
YoY Gr. Rt. %-23.8%19.7%5.6%11.4%15.7%15.4%10.1%15.7%17.7%-
Adj EPS 44.5555.
YoY Gr. Rt. %-14.1%9%0.8%12.4%27.1%-3.1%39.4%34%10.7%-
BVPS (₹) 12.616.321.825.430.537.94348.699.4112.1117.6
Adj Net Profit 35.14043.74449.562.960.985124137147
Cash Flow from Ops. 38.365.363.361.95575.5113127116126-
Debt/CF from Ops. 1.311.


CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 14.9%14.9%14.4%17.7%
Adj EPS 15.3%20.6%27.4%10.7%
BVPS 27.529.837.612.8
Share Price 34.3% 29.4% 68.2% -5.3%

Key Financial Parameters

Performance Ratio Colour Code Guide

Return on Equity % 34.431.42621.220.120.817.12117.913.513.3
Op. Profit Mgn % 2725.522.621.921.423.922.825.128.224.323
Net Profit Mgn % 13.912.811.711.211.312.410.413.216.515.615.2
Debt to Equity
Working Cap Days 137132136144146157159173182177251
Cash Conv. Cycle 56525467758081787889169

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 14.44%

Net Profit is growing at healthy rate in last 3 years 27.37%

Sales growth is good in last 4 quarters at 19.11%

Return on Equity has declined versus last 3 years average to 13.30%

Latest Financials - Poly Medicure Ltd.

Standalone Consolidated
TTM EPS (₹) 15.3 14.7
TTM Sales (₹ Cr.) 967 1,011
BVPS (₹.) 117.6 118.3
Reserves (₹ Cr.) 1,080 1,087
P/BV 8.31 8.28
PE 63.90 66.53
From the Market
52 Week Low / High (₹) 652.30 / 1077.10
All Time Low / High (₹) 0.50 / 1163.00
Market Cap (₹ Cr.) 9,372
Equity (₹ Cr.) 48
Face Value (₹) 5
Industry PE 60.3

Management X-Ray of Poly Medicure :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Poly Medicure

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)


Poly Medicure Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Poly Medicure on 29-Nov-2022 18:01 is : 974.9.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 29-Nov-2022 18:01 the market cap of Poly Medicure stood at ₹ 9,371.7.
The latest PE ratio of Poly Medicure as of 29-Nov-2022 18:01 is 63.90.
The latest PB ratio of Poly Medicure as of 29-Nov-2022 18:01 is 8.31
The 52-week high of Poly Medicure is ₹ 1,077.1 and the 52-week low is ₹ 652.3.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue / sales of Poly Medicure is ₹ 967.5 ( Cr.) .

About Poly Medicure Ltd

Poly Medicure Ltd. was conceived and established by a group of engineers and technocrats dedicated to the idea of providing the benefits of modern healthcare to the mankind at affordable price. This unique philosophy has been the driving force behind the company since its inception in 1995. Today it has grown into one of the most dynamically versatile manufacturers of disposable healthcare products in the region with over 60 different products.

POLYMED manufactures its products using state of the art technology in ultra modern facilities covering over 300,000 square feet of manufacturing floor space with about 50,000 square feet of clean rooms of class 100,000 to class 1,000. A tool room with modern facilities & CNC machines supports the manufacturing processes. A high degree of automation and an effective process control helps in delivering consistent product quality.

To keep pace with the ever changing requirements of the market, POLYMED has a fully staffed and highly equipped R & D section to design and develop new and innovative products. Using the latest CAD/CAM technology, the new product development is fast and improvements, based on market response and customer feedback, are made with ease. Assuring world class products at affordable prices is the hall mark of POLYMED

Product range of the company:

The company manufactures different products related to :

  • Infusion Therapy
  • Central Venous Access Catheters
  • Anaesthesia
  • Urology
  • Gastroenterology
  • Blood Management
  • Surgery & Wound Drainage
  • Dialysis
  • Others

Achievements/ recognition:

  • QMS (Quality Management System) accredited by SGS
  • ISO 9001:2000
  • ISO-13485:2003
  • CE mark from DNV
  • US FDA 510k approved  
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now